David Michael Johnson is Director of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 192,818 shares of ZNTL, which is worth approximately $603,520. The most recent transaction as insider was on Jun 21, 2024, when has been sold 48,429 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 193K
0% 3M change
33.54% 12M change
Total Value Held $603,520

David Michael Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 21 2024
BUY
Grant, award, or other acquisition
-
48,429 Added 20.07%
192,818 Common Stock
Nov 10 2023
BUY
Open market or private purchase
$167,960 $9.88 p/Share
17,000 Added 10.53%
144,389 Common Stock
Jun 16 2023
BUY
Grant, award, or other acquisition
-
19,059 Added 13.01%
127,389 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
24,871 Added 18.67%
108,330 Common Stock
Oct 04 2021
SELL
Open market or private sale
$858,616 $66.58 p/Share
12,896 Reduced 13.74%
80,959 Common Stock
Jun 04 2021
BUY
Grant, award, or other acquisition
-
5,000 Added 5.06%
93,855 Common Stock
Apr 05 2021
SELL
Open market or private sale
$561,020 $43.5 p/Share
12,897 Reduced 12.67%
88,855 Common Stock
Dec 02 2020
SELL
Open market or private sale
$660,791 $51.24 p/Share
12,896 Reduced 11.25%
101,752 Common Stock
Apr 07 2020
BUY
Open market or private purchase
$72,000 $18.0 p/Share
4,000 Added 3.37%
114,648 Common Stock

Also insider at

AURA
Aura Biosciences, Inc. Healthcare
DMJ

David Michael Johnson

Director
New York, NY

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Track Activities on ZNTL